Clarametyx has promoted Steve St. Onge to Chief Business Officer and hired Brendan Doran as Senior Vice President of Clinical Development.

Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for ...

Medicus Pharma has carved out a niche in dermatological therapeutics, focusing on novel compounds and delivery systems ...

Sheila Gujrathi, former CEO of Gossamer Bio, has written a new book that aims to offer the type of leadership manual she ...

The impact of digital transformation, increased regulation, rising costs, bouncing tariffs and volatile geopolitics are just some of the big issues keeping Australian business leaders up at night.

In this role, Dr. Schayowitz will report directly to Zymeworks’ Chair & Chief Executive Officer, Kenneth Galbraith, and work closely with the Zymeworks R&D and Business Development teams to advance ...

Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, ...

Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced ...

Founded six years ago, BaysMartin Consulting operates within the life sciences sector, supporting clients at various stages ...